Posted On: 06/14/2014 4:25:04 AM
Post# of 56323
Since 6/4/14 a look at CMF shows that accumulation is occurring within a trading range of .056 low to .066 high and averaged pricing around .06
Overall volume during this period remains low with heavy short volume of 50.33% occurring Friday, June 13, 2014. It is very interesting to note that increased short volume did not significantly impact PPS like it has on previous occasions. I have placed GTC Limit orders at .0461 and will wait until mid week to see if accumulation continues to hold. If so, I will revise my GTC Limit order to .0595 - .0605 range.
Note that the longer it takes to become licensed the better it is for shareholders. I understand some will say this does not make sense so I will explain it this way.
1. The harder it is to obtain license the higher valued licensing becomes. As time goes on it will become harder to become licensed, not easier. This is because regulatory agencies and politics will have an ever increasing role as the mmj industry continues evolving.
2. What is seen as delays (currently) probably has more to do with changes to zoning or similar issues which are (or will be industry specific). IMO,This in no way is any risk whatsoever to FITX obtaining license and by delay occurring creates longer buying opportunity at pre license pricing (accumulation, like we are seeing right now)
3. Detriments to PPS AFTER licensing. There is currently no established means of sales or distribution so cost/revenues will not be consistent, nor are there any assurances of capturing market share. In addition, there are two key components that will impact PPS. (a) profit taking after license (b) enormous quantities of previously restricted shares will be sold to capitalize operations and will "appear" as some creative "profit share" agreement or new "lender, investor, etc", in reality, this will have a negative impact when shareholders do not see the increase to PPS they anticipate and price action will fluctuate within in large trading ranges.
Ultimately, the selling of formerly restricted shares by insiders will help the company finance operations and long term grow PPS as a result. Additional revenue streams will also be a factor as Hemp finds its way back into the US market. Also, it is a guess on my part that FITX may pay dividends to keep shareholders loyal. (Just a logical assumption on my part.)
My conclusion, use this opportunity to continue accumulating shares. After license, take some profits off the table buy selling some shares at he top of trading ranges then setting GTC BUY Limits within 10% of bottom ranges thereby accumulating as the company grows.
The above are my opinions and in no way should anyone ever use anything I ever provide here as a basis to buy or sell any stock at any time. Please due your own DD and TA. Again, these are only my personal opinions.
As always, I welcome your responses
Overall volume during this period remains low with heavy short volume of 50.33% occurring Friday, June 13, 2014. It is very interesting to note that increased short volume did not significantly impact PPS like it has on previous occasions. I have placed GTC Limit orders at .0461 and will wait until mid week to see if accumulation continues to hold. If so, I will revise my GTC Limit order to .0595 - .0605 range.
Note that the longer it takes to become licensed the better it is for shareholders. I understand some will say this does not make sense so I will explain it this way.
1. The harder it is to obtain license the higher valued licensing becomes. As time goes on it will become harder to become licensed, not easier. This is because regulatory agencies and politics will have an ever increasing role as the mmj industry continues evolving.
2. What is seen as delays (currently) probably has more to do with changes to zoning or similar issues which are (or will be industry specific). IMO,This in no way is any risk whatsoever to FITX obtaining license and by delay occurring creates longer buying opportunity at pre license pricing (accumulation, like we are seeing right now)
3. Detriments to PPS AFTER licensing. There is currently no established means of sales or distribution so cost/revenues will not be consistent, nor are there any assurances of capturing market share. In addition, there are two key components that will impact PPS. (a) profit taking after license (b) enormous quantities of previously restricted shares will be sold to capitalize operations and will "appear" as some creative "profit share" agreement or new "lender, investor, etc", in reality, this will have a negative impact when shareholders do not see the increase to PPS they anticipate and price action will fluctuate within in large trading ranges.
Ultimately, the selling of formerly restricted shares by insiders will help the company finance operations and long term grow PPS as a result. Additional revenue streams will also be a factor as Hemp finds its way back into the US market. Also, it is a guess on my part that FITX may pay dividends to keep shareholders loyal. (Just a logical assumption on my part.)
My conclusion, use this opportunity to continue accumulating shares. After license, take some profits off the table buy selling some shares at he top of trading ranges then setting GTC BUY Limits within 10% of bottom ranges thereby accumulating as the company grows.
The above are my opinions and in no way should anyone ever use anything I ever provide here as a basis to buy or sell any stock at any time. Please due your own DD and TA. Again, these are only my personal opinions.
As always, I welcome your responses
(0)
(0)Scroll down for more posts ▼
